Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences - Poll - MDSpire

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences

  • By

  • Maximilian Haack

  • Vanessa Miksch

  • Zhe Tian

  • Gregor Duwe

  • Anita Thomas

  • Angelika Borkowetz

  • Kristina Stroh

  • Christian Thomas

  • Axel Haferkamp

  • Thomas Höfner

  • Katharina Boehm

  • November 1, 2022

  • 0 min

Share

Original Source(s)

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences

  • by Maximilian Haack, Vanessa Miksch, Zhe Tian, Gregor Duwe, Anita Thomas, Angelika Borkowetz, Kristina Stroh, Christian Thomas, Axel Haferkamp, Thomas Höfner, Katharina Boehm

  • November 1, 2022

Related Content

Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project

Sharper Imaging, Smarter Tools: Inside the MonacoPro

With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.

Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores